help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turner, R. T.
Right arrow Articles by Morey-Holton, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turner, R. T.
Right arrow Articles by Morey-Holton, E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Osteoporosis
Hazardous Substances DB
*PARATHYROID HORMONE
Endocrinology Vol. 139, No. 10 4086-4091
Copyright © 1998 by The Endocrine Society


ARTICLES

Programmed Administration of Parathyroid Hormone Increases Bone Formation and Reduces Bone Loss in Hindlimb-Unloaded Ovariectomized Rats1

Russell T. Turner, Glenda L. Evans, Jason M. Cavolina, Bernard Halloran and Emily Morey-Holton

Departments of Orthopedics and Biochemistry and Molecular Biology (R.T.T., G.L.E., J.M.C.), Mayo Foundation, Rochester, Minnesota 55905; Veterans Administration Medical Center (B.H.), San Francisco, California 94121; and National Air and Space Administration, Ames Research Center (E.M.-H.), Moffett Field, California 94035

Address all correspondence and requests for reprints to: Russell T. Turner, Ph.D., Orthopedic Research, Room 3-69 Medical Science Building, Mayo Foundation, 200 First Street SW, Rochester, Minnesota 55905.

Gonadal insufficiency and reduced mechanical usage are two important risk factors for osteoporosis. The beneficial effects of PTH therapy to reverse the estrogen deficiency-induced bone loss in the laboratory rat are well known, but the influence of mechanical usage in this response has not been established. In this study, the effects of programed administration of PTH on cancellous bone volume and turnover at the proximal tibial metaphysis were determined in hindlimb-unloaded, ovariectomized (OVX), 3-month-old Sprague-Dawley rats. PTH was administered to weight-bearing and hindlimb-unloaded OVX rats with osmotic pumps programed to deliver 20 µg human PTH (~80 µg/kg·day) during a daily 1-h infusion for 7 days. Compared with sham-operated rats, OVX increased longitudinal and radial bone growth, increased indexes of cancellous bone turnover, and resulted in net resorption of cancellous bone. Hindlimb unloading of OVX rats decreased longitudinal and radial bone growth, decreased osteoblast number, increased osteoclast number, and resulted in a further decrease in cancellous bone volume compared with those in weight-bearing OVX rats. Programed administration of PTH had no effect on either radial or longitudinal bone growth in weight-bearing and hindlimb-unloaded OVX rats. PTH treatment had dramatic effects on selected cancellous bone measurements; PTH maintained cancellous bone volume in OVX weight-bearing rats and greatly reduced cancellous bone loss in OVX hindlimb-unloaded rats. In the latter animals, PTH treatment prevented the hindlimb unloading-induced reduction in trabecular thickness, but the hormone was ineffective in preventing either the increase in osteoclast number or the loss of trabecular plates. Importantly, PTH treatment increased the retention of a baseline flurochrome label, osteoblast number, and bone formation in the proximal tibial metaphysis regardless of the level of mechanical usage. These findings demonstrate that programed administration of PTH is effective in increasing osteoblast number and bone formation and has beneficial effects on bone volume in the absence of weight-bearing and gonadal hormones. We conclude that the actions of PTH on cancellous bone are independent of the level of mechanical usage.




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
R. T. Turner, S. Lotinun, T. E. Hefferan, and E. Morey-Holton
Disuse in adult male rats attenuates the bone anabolic response to a therapeutic dose of parathyroid hormone
J Appl Physiol, September 1, 2006; 101(3): 881 - 886.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
S. W. Donahue, S. A. Galley, M. R. Vaughan, P. Patterson-Buckendahl, L. M. Demers, J. L. Vance, and M. E. McGee
Parathyroid hormone may maintain bone formation in hibernating black bears (Ursus americanus) to prevent disuse osteoporosis
J. Exp. Biol., May 1, 2006; 209(9): 1630 - 1638.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. E. Hefferan, G. L. Evans, S. Lotinun, M. Zhang, E. Morey-Holton, and R. T. Turner
Effect of gender on bone turnover in adult rats during simulated weightlessness
J Appl Physiol, November 1, 2003; 95(5): 1775 - 1780.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. D. Bakker, M. Joldersma, J. Klein-Nulend, and E. H. Burger
Interactive effects of PTH and mechanical stress on nitric oxide and PGE2 production by primary mouse osteoblastic cells
Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E608 - E613.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Joldersma, J. Klein-Nulend, A. M. Oleksik, I. C. Heyligers, and E. H. Burger
Estrogen enhances mechanical stress-induced prostaglandin production by bone cells from elderly women
Am J Physiol Endocrinol Metab, March 1, 2001; 280(3): E436 - E442.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society